Integrated Diagnostics Current Valuation vs. Shares Owned By Institutions
| IDHC Stock | 0.44 0.01 2.22% |
For Integrated Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Integrated Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Integrated Diagnostics Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Integrated Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Integrated Diagnostics Holdings over time as well as its relative position and ranking within its peers.
Integrated |
Integrated Diagnostics Shares Owned By Institutions vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Integrated Diagnostics's current stock value. Our valuation model uses many indicators to compare Integrated Diagnostics value to that of its competitors to determine the firm's financial worth. Integrated Diagnostics Holdings is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in shares owned by institutions category among its peers . The ratio of Current Valuation to Shares Owned By Institutions for Integrated Diagnostics Holdings is about 6,176,187 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integrated Diagnostics' earnings, one of the primary drivers of an investment's value.Integrated Current Valuation vs. Competition
Integrated Diagnostics Holdings is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 310.86 Million. Integrated Diagnostics totals roughly 261.19 Million in current valuation claiming about 84% of equities under Health Care industry.
Integrated Shares Owned By Institutions vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Integrated Diagnostics |
| = | 261.19 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Integrated Diagnostics |
| = | 42.29 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Integrated Shares Owned By Institutions Comparison
Integrated Diagnostics is currently under evaluation in shares owned by institutions category among its peers.
Integrated Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Integrated Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Integrated Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of Integrated Diagnostics' change in net profit over the period of time. It can combine multiple indicators of Integrated Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -753.2 M | -715.6 M | |
| Operating Income | 737.8 M | 765.5 M | |
| Income Before Tax | 737.4 M | 729.5 M | |
| Total Other Income Expense Net | -406 K | -426.3 K | |
| Net Income | 737.4 M | 723.7 M | |
| Income Tax Expense | 269 M | 258.1 M | |
| Net Income From Continuing Ops | 468.4 M | 511.4 M | |
| Net Income Applicable To Common Shares | 1.6 B | 1.7 B | |
| Net Interest Income | -88.2 M | -83.8 M | |
| Interest Income | 72.8 M | 70.1 M | |
| Change To Netincome | 575.2 M | 604 M |
Integrated Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Integrated Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Integrated Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Integrated Diagnostics' important profitability drivers and their relationship over time.
Use Integrated Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Integrated Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Diagnostics will appreciate offsetting losses from the drop in the long position's value.Integrated Diagnostics Pair Trading
Integrated Diagnostics Holdings Pair Trading Analysis
The ability to find closely correlated positions to Integrated Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Integrated Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Integrated Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Integrated Diagnostics Holdings to buy it.
The correlation of Integrated Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Integrated Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Integrated Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Integrated Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Integrated Diagnostics position
In addition to having Integrated Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Discretionary ETFs Thematic Idea Now
Consumer Discretionary ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.